New York, NY (PRWEB) April 25, 2012
MedMeme LLC., a global leader in providing comprehensive database platforms detailing medical and scientific information, announces the launch of new syndicated, therapeutic-category-focused reports that provide insight into how medical information is captured and communicated in order to create demand and shape biopharma markets, providing guidance for all segments of strategic planning.
“The MedMeme syndicated reports, 40 in all, identify key opinion leader physicians, institutions, and events that produced the information that create market demand in the world of medicine. These sources are the focus of our database. The reports parse data to look at factors shaping medical opinions and health care markets, right now. They’re comprehensive, accurate, and immediately actionable. Subscribers assess current trends, dominant players, rising stars, developments, the critical factors necessary for success in the given therapeutic category,” says MedMeme CEO, Mahesh Naithani.
A series of four reports based on MedMeme’s in-depth data make up the initial offering for each of the ten therapeutic categories. Each report will provide a current view of a therapeutic category from a particular perspective: TrendsMemeTM Reports are about key indications, companies, drugs, the status of a therapeutic category, and trends that are driving change and influencing R&D success; IntellMemeTM Reports identify the disease areas and drugs that receive the most attention at medical meetings and in peer-reviewed journal articles. They examine current practices, analyze trends over two to three years giving publication planners perspective guidance about where emphasis is in terms of exposure of indications for better clinical understanding; C-O-E/MemeTM Reports* pinpoint each of the top 50 medical centers-of-excellence by 10 specific therapeutic categories, giving guidance for selection of expert partners; TrialMemeTM Reports* identify, by location, leading clinical trial sites worldwide, including principal and site investigators, trial status, entity conducting the trial, drug, and where the results have been presented, knowledge to help reduce trial timelines and costs of future trials by providing historic perspective to sponsors and CROs.
These syndicated reports can be purchased separately, based on therapeutic category of interest, or by series at discounted pricing. To learn more about the reports, see http://www.medmeme.com/products/reports.
*Direct derivatives of the on-line, continuously updated, searchable database product platforms C-O-E/MemeTM and TrialMemeTM.